Prestige

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Prestige
Generic name: CHLOROXYLENOL
Manufacturer: Sunburst Chemicals, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 2e4bb97c-9c16-43d1-aea3-54723c7afc45
SPL ID: 14308390-5ca6-80b4-e063-6294a90a02ee
Version: 4
Effective date: 2024-03-21
Source export date: 2026-11-06
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/7dfa569f2d8f065241260fd9a4886d0ef0a3120fd6ee31d6d07c234e689e8c91/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 8dff71fbef1291eb7711013e9a3a06194930757924a8946ae3034107a98d9463
Import run: 20261106T075659Z
Imported at: 2026-11-06 08:20:11

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		505G(a)(3)	openfda.application_number
brand name		Prestige	openfda.brand_name
generic name		CHLOROXYLENOL	openfda.generic_name
manufacturer name		Sunburst Chemicals, Inc.	openfda.manufacturer_name
ndc	package	63621-335-14	openfda.package_ndc
ndc	product	63621-335	openfda.product_ndc
ndc11	package	63621033514	derived:openfda.package_ndc
rxcui		413257	openfda.rxcui
spl id		14308390-5ca6-80b4-e063-6294a90a02ee	id
spl set id		2e4bb97c-9c16-43d1-aea3-54723c7afc45	set_id
unii		0F32U78V2Q	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use in eyes. Discontinue use if irritation and redness develop. If condition persists for more than 72 hours, consult a physician. Not for use on children under 6 months of age. For institutional and professional use only.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.